| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aldosterone | 65 | 2024 | 868 | 8.250 |
Why?
|
| Receptors, Mineralocorticoid | 22 | 2024 | 164 | 3.870 |
Why?
|
| Spironolactone | 19 | 2023 | 411 | 2.590 |
Why?
|
| Hypoglycemia | 13 | 2023 | 888 | 2.240 |
Why?
|
| Sodium, Dietary | 20 | 2020 | 425 | 1.930 |
Why?
|
| Angiotensin II | 29 | 2023 | 849 | 1.900 |
Why?
|
| Hypertension | 36 | 2024 | 8594 | 1.900 |
Why?
|
| Renin-Angiotensin System | 24 | 2022 | 738 | 1.880 |
Why?
|
| Diet, Sodium-Restricted | 16 | 2023 | 291 | 1.690 |
Why?
|
| Hyperaldosteronism | 6 | 2021 | 244 | 1.660 |
Why?
|
| Blood Pressure | 49 | 2024 | 8525 | 1.630 |
Why?
|
| Caveolin 1 | 12 | 2020 | 257 | 1.620 |
Why?
|
| Baroreflex | 5 | 2023 | 148 | 1.460 |
Why?
|
| Insulin Resistance | 22 | 2024 | 3959 | 1.420 |
Why?
|
| Blood Glucose | 23 | 2023 | 6381 | 1.200 |
Why?
|
| Glucose Clamp Technique | 10 | 2023 | 263 | 1.130 |
Why?
|
| Adrenal Glands | 8 | 2020 | 554 | 1.090 |
Why?
|
| NG-Nitroarginine Methyl Ester | 12 | 2023 | 260 | 1.040 |
Why?
|
| Fibromyalgia | 8 | 2015 | 401 | 1.020 |
Why?
|
| Autonomic Nervous System | 6 | 2022 | 697 | 1.010 |
Why?
|
| Sodium Chloride, Dietary | 14 | 2024 | 293 | 1.000 |
Why?
|
| Receptor, Angiotensin, Type 1 | 6 | 2011 | 148 | 0.980 |
Why?
|
| Renin | 21 | 2024 | 635 | 0.910 |
Why?
|
| Neurosecretory Systems | 4 | 2009 | 221 | 0.870 |
Why?
|
| Rats, Wistar | 24 | 2023 | 1850 | 0.860 |
Why?
|
| Obesity | 22 | 2024 | 12922 | 0.820 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 3 | 2017 | 278 | 0.810 |
Why?
|
| Calmodulin-Binding Proteins | 7 | 2021 | 232 | 0.790 |
Why?
|
| Insulin | 22 | 2023 | 6597 | 0.790 |
Why?
|
| Cardiovascular System | 5 | 2015 | 850 | 0.780 |
Why?
|
| Food Preservatives | 1 | 2021 | 11 | 0.780 |
Why?
|
| Zona Glomerulosa | 8 | 2021 | 87 | 0.760 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2023 | 12293 | 0.720 |
Why?
|
| Cosyntropin | 1 | 2020 | 34 | 0.720 |
Why?
|
| Autonomic Nervous System Diseases | 2 | 2020 | 269 | 0.690 |
Why?
|
| Oxytocin | 3 | 2018 | 401 | 0.670 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2023 | 3334 | 0.660 |
Why?
|
| Cardiovascular Diseases | 15 | 2023 | 15757 | 0.660 |
Why?
|
| Glucose | 14 | 2021 | 4351 | 0.650 |
Why?
|
| Aortic Rupture | 1 | 2022 | 317 | 0.640 |
Why?
|
| Adipose Tissue | 10 | 2017 | 3301 | 0.610 |
Why?
|
| Coronary Circulation | 3 | 2018 | 1577 | 0.590 |
Why?
|
| Polymorphism, Single Nucleotide | 14 | 2023 | 15789 | 0.590 |
Why?
|
| Epinephrine | 13 | 2023 | 791 | 0.570 |
Why?
|
| Aortic Aneurysm | 1 | 2022 | 648 | 0.570 |
Why?
|
| Myocardium | 10 | 2021 | 4700 | 0.530 |
Why?
|
| Pancreatitis | 11 | 1999 | 1100 | 0.510 |
Why?
|
| Gene Frequency | 11 | 2018 | 3615 | 0.510 |
Why?
|
| Potassium | 7 | 2020 | 1313 | 0.500 |
Why?
|
| Dental Caries | 2 | 2017 | 420 | 0.500 |
Why?
|
| Endothelium, Vascular | 4 | 2013 | 4433 | 0.490 |
Why?
|
| Hydrocortisone | 14 | 2020 | 1803 | 0.490 |
Why?
|
| Lectins | 1 | 2017 | 484 | 0.480 |
Why?
|
| Male | 155 | 2024 | 359744 | 0.480 |
Why?
|
| Adrenocorticotropic Hormone | 10 | 2015 | 618 | 0.450 |
Why?
|
| Dyslipidemias | 2 | 2020 | 895 | 0.440 |
Why?
|
| Adult | 106 | 2024 | 219994 | 0.440 |
Why?
|
| Estradiol | 5 | 2012 | 1932 | 0.440 |
Why?
|
| Interleukin-6 | 5 | 2023 | 3215 | 0.430 |
Why?
|
| Diabetic Angiopathies | 2 | 2017 | 822 | 0.420 |
Why?
|
| Lipid Metabolism | 5 | 2016 | 1902 | 0.420 |
Why?
|
| Kidney | 12 | 2023 | 7064 | 0.420 |
Why?
|
| Vagus Nerve | 1 | 2015 | 458 | 0.420 |
Why?
|
| Abortion, Spontaneous | 1 | 2018 | 530 | 0.420 |
Why?
|
| Pericardium | 1 | 2017 | 675 | 0.410 |
Why?
|
| Heart | 5 | 2019 | 4393 | 0.410 |
Why?
|
| Norepinephrine | 10 | 2010 | 900 | 0.410 |
Why?
|
| Female | 130 | 2024 | 391270 | 0.410 |
Why?
|
| Humans | 191 | 2024 | 760621 | 0.410 |
Why?
|
| Apolipoproteins E | 2 | 2018 | 1436 | 0.410 |
Why?
|
| RNA, Messenger | 27 | 2023 | 12766 | 0.400 |
Why?
|
| Hydrochlorothiazide | 2 | 2014 | 94 | 0.400 |
Why?
|
| Corticotropin-Releasing Hormone | 7 | 2014 | 361 | 0.390 |
Why?
|
| Middle Aged | 100 | 2024 | 220352 | 0.390 |
Why?
|
| Stress, Psychological | 4 | 2012 | 4446 | 0.380 |
Why?
|
| Angiotensinogen | 3 | 2021 | 161 | 0.380 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2008 | 1112 | 0.370 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 2009 | 239 | 0.370 |
Why?
|
| Arteritis | 2 | 2024 | 162 | 0.370 |
Why?
|
| Adiponectin | 3 | 2017 | 1115 | 0.370 |
Why?
|
| Rats | 29 | 2023 | 23711 | 0.370 |
Why?
|
| Enalapril | 3 | 2018 | 313 | 0.370 |
Why?
|
| Vasoconstriction | 7 | 2015 | 593 | 0.360 |
Why?
|
| Signal Transduction | 20 | 2021 | 23376 | 0.360 |
Why?
|
| Microcirculation | 2 | 2014 | 1278 | 0.360 |
Why?
|
| Nerve Tissue Proteins | 7 | 2021 | 4407 | 0.350 |
Why?
|
| Double-Blind Method | 13 | 2020 | 12427 | 0.350 |
Why?
|
| Animals | 84 | 2023 | 167963 | 0.350 |
Why?
|
| Adrenalectomy | 3 | 2021 | 348 | 0.350 |
Why?
|
| Diuretics | 3 | 2014 | 613 | 0.340 |
Why?
|
| Diabetic Nephropathies | 2 | 2007 | 988 | 0.330 |
Why?
|
| Pituitary-Adrenal System | 3 | 2015 | 552 | 0.330 |
Why?
|
| Helicobacter pylori | 5 | 1999 | 377 | 0.330 |
Why?
|
| Factor V | 1 | 2010 | 168 | 0.330 |
Why?
|
| Helicobacter Infections | 5 | 1999 | 386 | 0.330 |
Why?
|
| Promoter Regions, Genetic | 4 | 2017 | 5785 | 0.320 |
Why?
|
| Histone Demethylases | 4 | 2019 | 323 | 0.320 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2021 | 17790 | 0.320 |
Why?
|
| Gene Expression Regulation | 14 | 2018 | 11903 | 0.320 |
Why?
|
| Cross-Over Studies | 4 | 2021 | 2061 | 0.310 |
Why?
|
| Renal Plasma Flow | 2 | 2021 | 27 | 0.310 |
Why?
|
| Diet, Reducing | 4 | 2004 | 488 | 0.300 |
Why?
|
| Simvastatin | 2 | 2023 | 352 | 0.300 |
Why?
|
| Vasodilation | 6 | 2021 | 962 | 0.290 |
Why?
|
| Membrane Proteins | 9 | 2021 | 7850 | 0.290 |
Why?
|
| Sodium | 7 | 2024 | 1594 | 0.290 |
Why?
|
| Oxidoreductases, N-Demethylating | 3 | 2012 | 110 | 0.290 |
Why?
|
| Heart Rate | 4 | 2022 | 4179 | 0.290 |
Why?
|
| Fenfluramine | 2 | 1998 | 58 | 0.290 |
Why?
|
| Sex Factors | 8 | 2021 | 10547 | 0.290 |
Why?
|
| Nitric Oxide | 8 | 2015 | 2141 | 0.290 |
Why?
|
| Adiposity | 4 | 2018 | 1858 | 0.290 |
Why?
|
| Lipolysis | 4 | 2002 | 211 | 0.280 |
Why?
|
| Young Adult | 24 | 2024 | 58741 | 0.280 |
Why?
|
| Pancreas | 10 | 1999 | 1677 | 0.280 |
Why?
|
| Appetite Depressants | 2 | 1998 | 108 | 0.280 |
Why?
|
| HIV Infections | 11 | 2024 | 17165 | 0.280 |
Why?
|
| Proteinuria | 2 | 2006 | 594 | 0.270 |
Why?
|
| Inflammation | 7 | 2019 | 10756 | 0.270 |
Why?
|
| Alleles | 10 | 2021 | 6898 | 0.270 |
Why?
|
| Receptors, Cell Surface | 6 | 2016 | 2825 | 0.270 |
Why?
|
| Antihypertensive Agents | 4 | 2013 | 2061 | 0.270 |
Why?
|
| Hemodynamics | 6 | 2021 | 4174 | 0.260 |
Why?
|
| Body Mass Index | 17 | 2018 | 12914 | 0.260 |
Why?
|
| Sympathetic Nervous System | 4 | 2022 | 520 | 0.260 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2013 | 1485 | 0.260 |
Why?
|
| Adolescent | 30 | 2024 | 87810 | 0.260 |
Why?
|
| Hyperinsulinism | 3 | 2010 | 402 | 0.250 |
Why?
|
| Nitric Oxide Synthase Type III | 6 | 2013 | 704 | 0.250 |
Why?
|
| Memory | 1 | 2015 | 2179 | 0.250 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 1726 | 0.250 |
Why?
|
| Caloric Restriction | 2 | 2018 | 296 | 0.250 |
Why?
|
| Social Behavior | 1 | 2012 | 1131 | 0.250 |
Why?
|
| Estrogen Receptor beta | 2 | 2021 | 168 | 0.250 |
Why?
|
| Cholelithiasis | 3 | 1998 | 408 | 0.250 |
Why?
|
| Poland | 3 | 2017 | 196 | 0.250 |
Why?
|
| Prediabetic State | 2 | 2024 | 550 | 0.240 |
Why?
|
| Aging | 5 | 2012 | 8651 | 0.240 |
Why?
|
| Intra-Abdominal Fat | 3 | 2015 | 608 | 0.230 |
Why?
|
| Hormones | 5 | 2014 | 867 | 0.230 |
Why?
|
| Diabetes Mellitus | 6 | 2018 | 5889 | 0.230 |
Why?
|
| Up-Regulation | 5 | 2015 | 4122 | 0.230 |
Why?
|
| Hypoglycemic Agents | 6 | 2023 | 3150 | 0.220 |
Why?
|
| Coronary Artery Disease | 3 | 2021 | 6659 | 0.220 |
Why?
|
| Benzhydryl Compounds | 1 | 2010 | 941 | 0.220 |
Why?
|
| Sleep Deprivation | 1 | 2010 | 840 | 0.220 |
Why?
|
| Hyperglycemia | 4 | 2020 | 1380 | 0.220 |
Why?
|
| Fibrinogen | 2 | 1998 | 886 | 0.210 |
Why?
|
| Reference Values | 7 | 2010 | 4925 | 0.210 |
Why?
|
| Heart Diseases | 2 | 2009 | 2809 | 0.210 |
Why?
|
| Aged | 42 | 2024 | 169152 | 0.210 |
Why?
|
| Cholesterol | 6 | 2020 | 2924 | 0.210 |
Why?
|
| Circadian Rhythm | 4 | 2020 | 2571 | 0.210 |
Why?
|
| Weight Loss | 3 | 2000 | 2686 | 0.210 |
Why?
|
| Hippocampus | 1 | 2015 | 3738 | 0.200 |
Why?
|
| Homeostasis | 6 | 2020 | 3306 | 0.200 |
Why?
|
| Calcium Channels, L-Type | 1 | 2023 | 240 | 0.200 |
Why?
|
| Aorta | 5 | 2015 | 2039 | 0.200 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2008 | 1206 | 0.200 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2021 | 700 | 0.200 |
Why?
|
| Leukocyte Rolling | 1 | 2021 | 69 | 0.190 |
Why?
|
| Body Weight | 6 | 2013 | 4611 | 0.190 |
Why?
|
| Triglycerides | 7 | 2016 | 2476 | 0.190 |
Why?
|
| Urea | 4 | 1999 | 446 | 0.190 |
Why?
|
| Models, Animal | 4 | 2013 | 2117 | 0.190 |
Why?
|
| Mice | 39 | 2021 | 81208 | 0.190 |
Why?
|
| Human Growth Hormone | 2 | 2003 | 638 | 0.190 |
Why?
|
| Liver | 10 | 2016 | 7509 | 0.190 |
Why?
|
| Cytochrome P-450 Enzyme System | 3 | 1994 | 412 | 0.190 |
Why?
|
| Dyspepsia | 2 | 1999 | 118 | 0.190 |
Why?
|
| C-Peptide | 2 | 2020 | 433 | 0.190 |
Why?
|
| Pravastatin | 1 | 2023 | 393 | 0.190 |
Why?
|
| Thyrotropin | 3 | 2021 | 832 | 0.180 |
Why?
|
| Propionates | 1 | 2021 | 182 | 0.180 |
Why?
|
| Hormone Antagonists | 2 | 2000 | 108 | 0.180 |
Why?
|
| Macrophages, Peritoneal | 1 | 2021 | 237 | 0.180 |
Why?
|
| Stroke | 1 | 2023 | 9962 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 5 | 2001 | 1959 | 0.180 |
Why?
|
| Arachidonic Acids | 1 | 2021 | 294 | 0.180 |
Why?
|
| Haplotypes | 4 | 2017 | 2764 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 14 | 2013 | 10827 | 0.170 |
Why?
|
| Risk Factors | 24 | 2023 | 74359 | 0.170 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2003 | 1928 | 0.170 |
Why?
|
| Food, Formulated | 1 | 2000 | 102 | 0.170 |
Why?
|
| Social Support | 1 | 2009 | 2145 | 0.170 |
Why?
|
| Muscle Fatigue | 1 | 2000 | 93 | 0.170 |
Why?
|
| Gadolinium DTPA | 5 | 2013 | 823 | 0.170 |
Why?
|
| Transforming Growth Factor alpha | 4 | 2001 | 135 | 0.170 |
Why?
|
| DMF Index | 2 | 2017 | 87 | 0.170 |
Why?
|
| Second Messenger Systems | 4 | 1999 | 202 | 0.170 |
Why?
|
| Aminopeptidases | 1 | 2019 | 95 | 0.170 |
Why?
|
| Breath Tests | 4 | 2002 | 297 | 0.160 |
Why?
|
| Brachial Artery | 2 | 2013 | 366 | 0.160 |
Why?
|
| Vasoconstrictor Agents | 7 | 2015 | 651 | 0.160 |
Why?
|
| Chronobiology Disorders | 1 | 2020 | 72 | 0.160 |
Why?
|
| Energy Metabolism | 2 | 2020 | 2869 | 0.160 |
Why?
|
| Adipokines | 2 | 2013 | 311 | 0.160 |
Why?
|
| C-Reactive Protein | 2 | 2023 | 3839 | 0.160 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2019 | 293 | 0.160 |
Why?
|
| Serotonin Antagonists | 1 | 1999 | 144 | 0.160 |
Why?
|
| Renal Artery | 1 | 2000 | 370 | 0.160 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 1998 | 43 | 0.150 |
Why?
|
| Pituitary Gland | 2 | 1998 | 637 | 0.150 |
Why?
|
| Adenylate Kinase | 1 | 2018 | 102 | 0.150 |
Why?
|
| HIV | 2 | 2023 | 1579 | 0.150 |
Why?
|
| Mice, Knockout | 14 | 2020 | 14372 | 0.150 |
Why?
|
| Glycerol | 5 | 2007 | 276 | 0.150 |
Why?
|
| Tetanus Toxoid | 1 | 1998 | 193 | 0.150 |
Why?
|
| Physical Endurance | 1 | 2000 | 363 | 0.150 |
Why?
|
| Hypertension, Renal | 2 | 2021 | 141 | 0.150 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 1999 | 301 | 0.150 |
Why?
|
| Endocrine System | 1 | 1998 | 112 | 0.150 |
Why?
|
| Stomach | 2 | 1999 | 694 | 0.150 |
Why?
|
| Cyclic GMP | 3 | 2015 | 395 | 0.150 |
Why?
|
| Ammonia | 2 | 2014 | 236 | 0.150 |
Why?
|
| Enzyme Inhibitors | 7 | 2015 | 3726 | 0.150 |
Why?
|
| Proglumide | 1 | 1997 | 3 | 0.140 |
Why?
|
| Zona Reticularis | 1 | 2017 | 8 | 0.140 |
Why?
|
| Receptors, Cholecystokinin | 1 | 1997 | 18 | 0.140 |
Why?
|
| Hepatocyte Growth Factor | 1 | 1999 | 267 | 0.140 |
Why?
|
| Estrogens | 2 | 2014 | 1520 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 11 | 2009 | 5351 | 0.140 |
Why?
|
| Natriuretic Peptides | 1 | 2018 | 156 | 0.140 |
Why?
|
| Aorta, Thoracic | 2 | 2021 | 1097 | 0.140 |
Why?
|
| Metformin | 3 | 2018 | 912 | 0.140 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1999 | 590 | 0.140 |
Why?
|
| Peptic Ulcer | 1 | 1998 | 219 | 0.140 |
Why?
|
| Atherosclerosis | 2 | 2024 | 3517 | 0.140 |
Why?
|
| Albuminuria | 3 | 2019 | 659 | 0.140 |
Why?
|
| Sex Characteristics | 2 | 2021 | 2629 | 0.140 |
Why?
|
| Hypothyroidism | 1 | 2021 | 665 | 0.130 |
Why?
|
| Calcitriol | 1 | 2018 | 297 | 0.130 |
Why?
|
| PPAR gamma | 2 | 2010 | 484 | 0.130 |
Why?
|
| Mice, Obese | 2 | 2015 | 420 | 0.130 |
Why?
|
| Bile | 5 | 1997 | 296 | 0.130 |
Why?
|
| Endothelin-1 | 1 | 2017 | 302 | 0.130 |
Why?
|
| Pancreatic Polypeptide | 1 | 1995 | 34 | 0.130 |
Why?
|
| Cyclic AMP | 3 | 1992 | 1456 | 0.130 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 1998 | 314 | 0.130 |
Why?
|
| Neurons, Afferent | 1 | 1998 | 498 | 0.130 |
Why?
|
| Body Composition | 3 | 2020 | 2419 | 0.130 |
Why?
|
| Membrane Glycoproteins | 3 | 2021 | 3707 | 0.130 |
Why?
|
| Adrenal Cortex | 2 | 1994 | 134 | 0.130 |
Why?
|
| Cell Adhesion | 2 | 2021 | 3094 | 0.130 |
Why?
|
| Thyroid Gland | 2 | 2021 | 1168 | 0.130 |
Why?
|
| Caffeine | 1 | 2000 | 702 | 0.130 |
Why?
|
| Aortic Diseases | 1 | 2021 | 736 | 0.130 |
Why?
|
| Reflex, Abnormal | 1 | 2015 | 83 | 0.130 |
Why?
|
| Dinoprost | 1 | 1995 | 138 | 0.130 |
Why?
|
| Hyperlipidemias | 1 | 2020 | 782 | 0.120 |
Why?
|
| Ovariectomy | 2 | 2008 | 611 | 0.120 |
Why?
|
| Bradykinin | 1 | 1995 | 208 | 0.120 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2015 | 105 | 0.120 |
Why?
|
| Alpha Rhythm | 1 | 2015 | 109 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2007 | 3455 | 0.120 |
Why?
|
| Delta Rhythm | 1 | 2015 | 81 | 0.120 |
Why?
|
| Liver Cirrhosis, Alcoholic | 3 | 2002 | 64 | 0.120 |
Why?
|
| Chemokine CCL2 | 2 | 2016 | 605 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2021 | 2290 | 0.120 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 1377 | 0.120 |
Why?
|
| Activity Cycles | 1 | 2014 | 47 | 0.120 |
Why?
|
| Prospective Studies | 16 | 2023 | 54303 | 0.120 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2014 | 1523 | 0.120 |
Why?
|
| Lipocalins | 1 | 2015 | 161 | 0.120 |
Why?
|
| Lactic Acid | 4 | 2009 | 1134 | 0.110 |
Why?
|
| Protein Kinase C | 4 | 1999 | 1199 | 0.110 |
Why?
|
| Stimulation, Chemical | 2 | 2010 | 306 | 0.110 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 1995 | 84 | 0.110 |
Why?
|
| Indoles | 2 | 1999 | 1829 | 0.110 |
Why?
|
| Steroid Hydroxylases | 1 | 1993 | 96 | 0.110 |
Why?
|
| Punctures | 1 | 1995 | 370 | 0.110 |
Why?
|
| Glucagon | 5 | 1998 | 532 | 0.110 |
Why?
|
| Gallbladder | 1 | 1995 | 305 | 0.110 |
Why?
|
| Receptors, Estrogen | 2 | 2014 | 2210 | 0.110 |
Why?
|
| Hypothalamus | 2 | 1998 | 998 | 0.110 |
Why?
|
| Crohn Disease | 6 | 2003 | 2275 | 0.110 |
Why?
|
| Angiotensin I | 1 | 2013 | 56 | 0.110 |
Why?
|
| Captopril | 1 | 2013 | 265 | 0.110 |
Why?
|
| Lithotripsy | 1 | 1994 | 142 | 0.110 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2012 | 30 | 0.110 |
Why?
|
| Muscle Relaxation | 2 | 2010 | 138 | 0.100 |
Why?
|
| 3T3-L1 Cells | 2 | 2015 | 209 | 0.100 |
Why?
|
| Nitric Oxide Synthase | 3 | 2010 | 908 | 0.100 |
Why?
|
| Stress, Physiological | 3 | 2012 | 1398 | 0.100 |
Why?
|
| Pancreatin | 1 | 1992 | 9 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2018 | 4490 | 0.100 |
Why?
|
| Amelogenin | 1 | 2012 | 14 | 0.100 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 1 | 2012 | 20 | 0.100 |
Why?
|
| Monocytes | 1 | 2021 | 2575 | 0.100 |
Why?
|
| Sodium Chloride | 2 | 2000 | 591 | 0.100 |
Why?
|
| Calorimetry, Indirect | 2 | 2010 | 174 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2000 | 1182 | 0.100 |
Why?
|
| Poly A | 1 | 1992 | 181 | 0.100 |
Why?
|
| Postprandial Period | 2 | 2012 | 315 | 0.100 |
Why?
|
| Caveolin 3 | 1 | 2011 | 24 | 0.100 |
Why?
|
| Diet | 5 | 2020 | 8010 | 0.100 |
Why?
|
| Muscle, Skeletal | 2 | 2013 | 4925 | 0.100 |
Why?
|
| Diabetic Neuropathies | 1 | 1995 | 406 | 0.100 |
Why?
|
| Fumarates | 1 | 2012 | 131 | 0.100 |
Why?
|
| Pituitary Gland, Anterior | 2 | 1990 | 142 | 0.100 |
Why?
|
| Energy Intake | 1 | 1999 | 2129 | 0.100 |
Why?
|
| Genotype | 11 | 2021 | 12960 | 0.100 |
Why?
|
| Sleep Stages | 1 | 2015 | 691 | 0.090 |
Why?
|
| Analysis of Variance | 3 | 2012 | 6238 | 0.090 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2013 | 361 | 0.090 |
Why?
|
| Kinetics | 7 | 1999 | 6377 | 0.090 |
Why?
|
| Drug Therapy, Combination | 2 | 2014 | 6498 | 0.090 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2016 | 733 | 0.090 |
Why?
|
| Glucose Tolerance Test | 2 | 2012 | 1175 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2019 | 2058 | 0.090 |
Why?
|
| Mannose-Binding Lectin | 1 | 2012 | 146 | 0.090 |
Why?
|
| Gene Expression | 7 | 2021 | 7588 | 0.090 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 2420 | 0.090 |
Why?
|
| Transcription, Genetic | 7 | 2021 | 7593 | 0.090 |
Why?
|
| Duodenogastric Reflux | 1 | 2009 | 4 | 0.090 |
Why?
|
| Regeneration | 1 | 1999 | 1506 | 0.090 |
Why?
|
| Antibodies | 1 | 1998 | 2421 | 0.090 |
Why?
|
| Amides | 1 | 2012 | 448 | 0.090 |
Why?
|
| Arginine | 4 | 1998 | 934 | 0.090 |
Why?
|
| Models, Neurological | 2 | 2015 | 1758 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 9 | 2021 | 22023 | 0.090 |
Why?
|
| Pain | 4 | 2005 | 5066 | 0.080 |
Why?
|
| Colitis, Ulcerative | 2 | 1999 | 1919 | 0.080 |
Why?
|
| Data Mining | 1 | 2014 | 553 | 0.080 |
Why?
|
| Immediate-Early Proteins | 1 | 2012 | 449 | 0.080 |
Why?
|
| Projection | 1 | 1989 | 18 | 0.080 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2009 | 80 | 0.080 |
Why?
|
| Wakefulness | 2 | 2010 | 1255 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 11 | 2001 | 6131 | 0.080 |
Why?
|
| Basal Metabolism | 1 | 2010 | 161 | 0.080 |
Why?
|
| Calcium | 3 | 1999 | 5725 | 0.080 |
Why?
|
| Germany | 6 | 2009 | 873 | 0.080 |
Why?
|
| Phenylephrine | 3 | 2015 | 293 | 0.080 |
Why?
|
| Thalamus | 1 | 2015 | 1041 | 0.080 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 18137 | 0.080 |
Why?
|
| Contrast Media | 4 | 2013 | 5305 | 0.080 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2010 | 763 | 0.080 |
Why?
|
| Necrosis | 3 | 2000 | 1612 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 6 | 2014 | 6068 | 0.080 |
Why?
|
| Polymorphism, Genetic | 5 | 2011 | 4291 | 0.080 |
Why?
|
| Infusions, Intravenous | 5 | 2007 | 2234 | 0.080 |
Why?
|
| Protein Kinase C-delta | 1 | 2008 | 114 | 0.080 |
Why?
|
| Bile Acids and Salts | 3 | 2003 | 382 | 0.080 |
Why?
|
| Pain Threshold | 1 | 2012 | 603 | 0.080 |
Why?
|
| U937 Cells | 2 | 2021 | 262 | 0.080 |
Why?
|
| Parasympathetic Nervous System | 1 | 2008 | 141 | 0.080 |
Why?
|
| Administration, Intranasal | 1 | 2009 | 471 | 0.080 |
Why?
|
| Hyperalgesia | 1 | 2012 | 530 | 0.080 |
Why?
|
| Lipids | 3 | 2018 | 3336 | 0.080 |
Why?
|
| United States | 4 | 2023 | 72461 | 0.080 |
Why?
|
| Trimipramine | 1 | 2007 | 3 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 1489 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2012 | 3106 | 0.070 |
Why?
|
| Premenopause | 2 | 2003 | 1038 | 0.070 |
Why?
|
| Electrocardiography | 2 | 2013 | 6414 | 0.070 |
Why?
|
| Blotting, Western | 7 | 2014 | 5039 | 0.070 |
Why?
|
| Finasteride | 1 | 2008 | 90 | 0.070 |
Why?
|
| Time Factors | 13 | 2020 | 40165 | 0.070 |
Why?
|
| Estrogen Receptor alpha | 2 | 2014 | 580 | 0.070 |
Why?
|
| Sex Distribution | 3 | 2009 | 2295 | 0.070 |
Why?
|
| Saliva | 1 | 2012 | 820 | 0.070 |
Why?
|
| Glutathione Peroxidase | 1 | 2008 | 256 | 0.070 |
Why?
|
| Cholecystectomy | 1 | 2009 | 406 | 0.070 |
Why?
|
| Leukotriene D4 | 2 | 1997 | 33 | 0.070 |
Why?
|
| Cardiomegaly | 1 | 2010 | 593 | 0.070 |
Why?
|
| Atrial Natriuretic Factor | 2 | 1998 | 350 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2013 | 1797 | 0.070 |
Why?
|
| Portal Vein | 3 | 1999 | 429 | 0.070 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 686 | 0.070 |
Why?
|
| Psychoanalytic Therapy | 1 | 1989 | 228 | 0.070 |
Why?
|
| Systole | 2 | 2006 | 947 | 0.070 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1987 | 114 | 0.070 |
Why?
|
| Veins | 1 | 2011 | 765 | 0.070 |
Why?
|
| Perfusion | 3 | 2023 | 1376 | 0.070 |
Why?
|
| Epididymis | 1 | 2008 | 228 | 0.070 |
Why?
|
| Renal Circulation | 1 | 2007 | 291 | 0.070 |
Why?
|
| Heterozygote | 2 | 2012 | 2798 | 0.070 |
Why?
|
| Symporters | 1 | 2009 | 361 | 0.070 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2007 | 186 | 0.070 |
Why?
|
| Streptozocin | 1 | 2006 | 194 | 0.070 |
Why?
|
| Body Constitution | 2 | 1998 | 273 | 0.070 |
Why?
|
| Treatment Outcome | 8 | 2024 | 65017 | 0.070 |
Why?
|
| Models, Biological | 5 | 2011 | 9467 | 0.070 |
Why?
|
| Arteries | 1 | 2011 | 1126 | 0.070 |
Why?
|
| Regional Blood Flow | 2 | 2007 | 1490 | 0.070 |
Why?
|
| Cells, Cultured | 9 | 2021 | 18957 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2008 | 594 | 0.060 |
Why?
|
| Object Attachment | 1 | 1989 | 324 | 0.060 |
Why?
|
| Dexamethasone | 3 | 1994 | 1927 | 0.060 |
Why?
|
| Receptors, Chemokine | 1 | 2009 | 655 | 0.060 |
Why?
|
| Phosphorylation | 6 | 2019 | 8313 | 0.060 |
Why?
|
| Prolactin | 2 | 1999 | 621 | 0.060 |
Why?
|
| Progesterone | 2 | 2007 | 742 | 0.060 |
Why?
|
| Environment | 1 | 2011 | 1118 | 0.060 |
Why?
|
| Enema | 2 | 2003 | 141 | 0.060 |
Why?
|
| Intestine, Small | 2 | 2003 | 1207 | 0.060 |
Why?
|
| Vasodilator Agents | 5 | 2011 | 978 | 0.060 |
Why?
|
| Enzyme Activation | 7 | 2001 | 3602 | 0.060 |
Why?
|
| Age Distribution | 2 | 2009 | 2893 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2015 | 36290 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 4 | 1999 | 818 | 0.060 |
Why?
|
| Proteins | 3 | 2012 | 6029 | 0.060 |
Why?
|
| Blotting, Northern | 6 | 1999 | 1543 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases | 3 | 2000 | 203 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2013 | 3157 | 0.060 |
Why?
|
| Neoplasm Proteins | 4 | 2009 | 3610 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1753 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2011 | 6551 | 0.060 |
Why?
|
| Acute Disease | 6 | 1999 | 7269 | 0.060 |
Why?
|
| Forearm | 1 | 2007 | 429 | 0.060 |
Why?
|
| Case-Control Studies | 8 | 2012 | 22053 | 0.060 |
Why?
|
| Hypertrophy | 1 | 2006 | 555 | 0.060 |
Why?
|
| Osteopontin | 1 | 2006 | 302 | 0.060 |
Why?
|
| Citalopram | 1 | 2007 | 402 | 0.060 |
Why?
|
| Gastrointestinal Agents | 2 | 1999 | 509 | 0.060 |
Why?
|
| Corticosterone | 2 | 2017 | 304 | 0.060 |
Why?
|
| Postmenopause | 2 | 2007 | 2509 | 0.060 |
Why?
|
| Molecular Sequence Data | 11 | 2010 | 17624 | 0.060 |
Why?
|
| Wine | 1 | 2004 | 167 | 0.060 |
Why?
|
| Sensitivity and Specificity | 7 | 2003 | 14660 | 0.060 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 2002 | 178 | 0.060 |
Why?
|
| Carbon Isotopes | 3 | 2002 | 459 | 0.060 |
Why?
|
| Base Sequence | 12 | 1998 | 12446 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2009 | 1152 | 0.060 |
Why?
|
| Cyclin D1 | 3 | 2001 | 451 | 0.060 |
Why?
|
| Exercise | 1 | 2000 | 5787 | 0.060 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2007 | 701 | 0.060 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2009 | 854 | 0.060 |
Why?
|
| Aerospace Medicine | 1 | 2004 | 95 | 0.050 |
Why?
|
| Microdialysis | 2 | 2002 | 160 | 0.050 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 3758 | 0.050 |
Why?
|
| G1 Phase | 2 | 2001 | 403 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2013 | 4357 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2011 | 3682 | 0.050 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2021 | 4555 | 0.050 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2003 | 28 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2018 | 9585 | 0.050 |
Why?
|
| Catecholamines | 3 | 1995 | 385 | 0.050 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2024 | 190 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2016 | 4573 | 0.050 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 25942 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2012 | 6360 | 0.050 |
Why?
|
| HEK293 Cells | 3 | 2021 | 4264 | 0.050 |
Why?
|
| Menstrual Cycle | 1 | 2006 | 536 | 0.050 |
Why?
|
| Predictive Value of Tests | 4 | 2012 | 15289 | 0.050 |
Why?
|
| Octopamine | 1 | 2002 | 43 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 1992 | 2145 | 0.050 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2002 | 43 | 0.050 |
Why?
|
| Lipogenesis | 1 | 2024 | 210 | 0.050 |
Why?
|
| Longevity | 1 | 2010 | 1050 | 0.050 |
Why?
|
| Guanine Nucleotides | 1 | 1982 | 55 | 0.050 |
Why?
|
| Phentolamine | 2 | 1999 | 102 | 0.050 |
Why?
|
| Gastroesophageal Reflux | 1 | 2009 | 816 | 0.050 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2022 | 129 | 0.050 |
Why?
|
| Chromogranins | 2 | 2000 | 161 | 0.050 |
Why?
|
| Cycloheximide | 2 | 1992 | 343 | 0.050 |
Why?
|
| Secretory Pathway | 1 | 2021 | 53 | 0.050 |
Why?
|
| Guanylate Cyclase | 2 | 2013 | 205 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2001 | 2802 | 0.050 |
Why?
|
| Central Nervous System Stimulants | 1 | 2010 | 1174 | 0.050 |
Why?
|
| Phenotype | 8 | 2014 | 16546 | 0.050 |
Why?
|
| Response Elements | 1 | 2003 | 308 | 0.050 |
Why?
|
| Edema | 3 | 2010 | 769 | 0.050 |
Why?
|
| DNA, Complementary | 3 | 1999 | 1991 | 0.050 |
Why?
|
| Phenylalanine | 1 | 2002 | 365 | 0.050 |
Why?
|
| Nucleotides | 1 | 2023 | 450 | 0.050 |
Why?
|
| Amlodipine | 1 | 2021 | 84 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 1998 | 4312 | 0.050 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2021 | 102 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2002 | 613 | 0.050 |
Why?
|
| Prognosis | 7 | 2021 | 29658 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2024 | 10344 | 0.050 |
Why?
|
| Thyroid Function Tests | 1 | 2021 | 289 | 0.040 |
Why?
|
| Probability | 2 | 2004 | 2475 | 0.040 |
Why?
|
| Echocardiography | 1 | 2013 | 4981 | 0.040 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2001 | 326 | 0.040 |
Why?
|
| Epoxide Hydrolases | 1 | 2021 | 122 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2013 | 5125 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 3 | 2015 | 899 | 0.040 |
Why?
|
| NF-kappa B | 2 | 1999 | 2488 | 0.040 |
Why?
|
| Leptin | 1 | 2008 | 1591 | 0.040 |
Why?
|
| Metaproterenol | 1 | 1999 | 3 | 0.040 |
Why?
|
| Propranolol | 2 | 1999 | 489 | 0.040 |
Why?
|
| Iodide Peroxidase | 1 | 2021 | 294 | 0.040 |
Why?
|
| Attention | 1 | 2010 | 2387 | 0.040 |
Why?
|
| Algorithms | 3 | 2015 | 13981 | 0.040 |
Why?
|
| omega-N-Methylarginine | 2 | 1997 | 108 | 0.040 |
Why?
|
| Plasmids | 5 | 1999 | 2275 | 0.040 |
Why?
|
| Lipopolysaccharides | 3 | 2003 | 2209 | 0.040 |
Why?
|
| Chronic Disease | 5 | 1999 | 9287 | 0.040 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 1999 | 56 | 0.040 |
Why?
|
| Cytokines | 2 | 2017 | 7343 | 0.040 |
Why?
|
| Adrenergic Agents | 1 | 1999 | 74 | 0.040 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2001 | 461 | 0.040 |
Why?
|
| Age Factors | 4 | 2019 | 18416 | 0.040 |
Why?
|
| Glomerulonephritis | 1 | 2001 | 337 | 0.040 |
Why?
|
| Follow-Up Studies | 7 | 2020 | 39261 | 0.040 |
Why?
|
| Sleep | 4 | 2020 | 4751 | 0.040 |
Why?
|
| Protein Kinases | 2 | 1999 | 1612 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2001 | 8515 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 1 | 2020 | 262 | 0.040 |
Why?
|
| Amino Acid Sequence | 8 | 2010 | 13451 | 0.040 |
Why?
|
| Carcinoid Tumor | 1 | 2000 | 228 | 0.040 |
Why?
|
| Isoindoles | 1 | 1998 | 36 | 0.040 |
Why?
|
| Trypsinogen | 1 | 1998 | 84 | 0.040 |
Why?
|
| Octreotide | 1 | 1999 | 153 | 0.040 |
Why?
|
| Fibrinogens, Abnormal | 1 | 1998 | 10 | 0.040 |
Why?
|
| Trypsin Inhibitor, Kunitz Soybean | 1 | 1998 | 11 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 2002 | 640 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2002 | 1146 | 0.040 |
Why?
|
| Workload | 1 | 2004 | 847 | 0.040 |
Why?
|
| Serum | 1 | 2019 | 211 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2001 | 801 | 0.040 |
Why?
|
| Fluoresceins | 1 | 1998 | 234 | 0.040 |
Why?
|
| Enzyme Stability | 1 | 2018 | 220 | 0.040 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 5209 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2018 | 203 | 0.040 |
Why?
|
| Urease | 1 | 1997 | 39 | 0.040 |
Why?
|
| Oxides | 1 | 2000 | 401 | 0.040 |
Why?
|
| Thigh | 1 | 1999 | 240 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2008 | 3663 | 0.040 |
Why?
|
| Dehydroepiandrosterone | 1 | 1999 | 257 | 0.040 |
Why?
|
| Patient Selection | 1 | 2010 | 4283 | 0.040 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2009 | 1724 | 0.040 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2017 | 56 | 0.040 |
Why?
|
| 5-Methylcytosine | 1 | 2018 | 146 | 0.040 |
Why?
|
| Ferric Compounds | 1 | 2000 | 377 | 0.040 |
Why?
|
| Sulfasalazine | 1 | 1998 | 84 | 0.040 |
Why?
|
| Receptors, Growth Factor | 1 | 1999 | 326 | 0.040 |
Why?
|
| DNA | 3 | 2018 | 7233 | 0.040 |
Why?
|
| Body Temperature | 1 | 2001 | 777 | 0.040 |
Why?
|
| Pyloric Antrum | 1 | 1997 | 66 | 0.040 |
Why?
|
| Trypsin | 1 | 1998 | 496 | 0.040 |
Why?
|
| Fatigue | 1 | 2005 | 1544 | 0.040 |
Why?
|
| Sensory Thresholds | 1 | 1999 | 377 | 0.040 |
Why?
|
| Sulfones | 1 | 2020 | 447 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 1998 | 461 | 0.040 |
Why?
|
| Losartan | 1 | 1999 | 265 | 0.040 |
Why?
|
| Sincalide | 1 | 1997 | 15 | 0.040 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2017 | 83 | 0.040 |
Why?
|
| Diet Records | 1 | 1999 | 427 | 0.040 |
Why?
|
| Substance P | 1 | 1998 | 333 | 0.040 |
Why?
|
| Taurocholic Acid | 1 | 1997 | 43 | 0.040 |
Why?
|
| Intestinal Neoplasms | 1 | 2000 | 311 | 0.040 |
Why?
|
| Cholagogues and Choleretics | 1 | 1997 | 37 | 0.040 |
Why?
|
| Gastrins | 1 | 1997 | 74 | 0.040 |
Why?
|
| Growth Substances | 1 | 1999 | 768 | 0.040 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1999 | 436 | 0.040 |
Why?
|
| Reflex | 1 | 1999 | 376 | 0.040 |
Why?
|
| Incidence | 2 | 2013 | 21392 | 0.040 |
Why?
|
| Hepatic Encephalopathy | 1 | 1998 | 144 | 0.040 |
Why?
|
| Protein Binding | 4 | 2014 | 9335 | 0.030 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 2016 | 13 | 0.030 |
Why?
|
| Fasting | 2 | 2011 | 1603 | 0.030 |
Why?
|
| Aldehyde Reductase | 1 | 2016 | 71 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 6465 | 0.030 |
Why?
|
| Posture | 1 | 2001 | 953 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 2 | 1999 | 351 | 0.030 |
Why?
|
| Overweight | 2 | 2024 | 2421 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 1997 | 700 | 0.030 |
Why?
|
| Genes, ras | 1 | 1999 | 655 | 0.030 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1998 | 179 | 0.030 |
Why?
|
| Bacteriological Techniques | 1 | 1997 | 279 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2006 | 478 | 0.030 |
Why?
|
| Pregnancy | 2 | 2018 | 29749 | 0.030 |
Why?
|
| Minerals | 1 | 2018 | 283 | 0.030 |
Why?
|
| Protein Biosynthesis | 3 | 1998 | 2105 | 0.030 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.030 |
Why?
|
| Cohort Studies | 5 | 2021 | 41335 | 0.030 |
Why?
|
| Transcription Factors | 4 | 2003 | 12103 | 0.030 |
Why?
|
| Dioxygenases | 1 | 2018 | 335 | 0.030 |
Why?
|
| HIV-1 | 2 | 2015 | 6849 | 0.030 |
Why?
|
| Food | 1 | 2001 | 771 | 0.030 |
Why?
|
| Occupational Diseases | 1 | 2004 | 1486 | 0.030 |
Why?
|
| Dipeptides | 1 | 1998 | 409 | 0.030 |
Why?
|
| Labetalol | 1 | 1995 | 29 | 0.030 |
Why?
|
| Resistin | 1 | 2016 | 172 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 1998 | 301 | 0.030 |
Why?
|
| Citric Acid | 1 | 1996 | 123 | 0.030 |
Why?
|
| Enteric Nervous System | 1 | 1999 | 212 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2018 | 3607 | 0.030 |
Why?
|
| Neurons | 1 | 2015 | 9426 | 0.030 |
Why?
|
| Pressure | 1 | 1999 | 1156 | 0.030 |
Why?
|
| Dibenzocycloheptenes | 1 | 2015 | 27 | 0.030 |
Why?
|
| Mutation | 5 | 2012 | 29932 | 0.030 |
Why?
|
| Cattle | 4 | 1996 | 3847 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1997 | 635 | 0.030 |
Why?
|
| Melatonin | 1 | 2001 | 668 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1998 | 506 | 0.030 |
Why?
|
| Nitrites | 1 | 1995 | 159 | 0.030 |
Why?
|
| Electric Impedance | 1 | 1999 | 755 | 0.030 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 1995 | 47 | 0.030 |
Why?
|
| Sodium Oxybate | 1 | 2015 | 33 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2024 | 2007 | 0.030 |
Why?
|
| Duodenal Ulcer | 1 | 1995 | 121 | 0.030 |
Why?
|
| Models, Statistical | 2 | 2015 | 5075 | 0.030 |
Why?
|
| Genes, MHC Class II | 1 | 1996 | 451 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 282 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2017 | 296 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1999 | 1304 | 0.030 |
Why?
|
| Indocyanine Green | 1 | 1997 | 236 | 0.030 |
Why?
|
| Stomach Ulcer | 1 | 1995 | 123 | 0.030 |
Why?
|
| Bone Diseases, Metabolic | 1 | 1999 | 409 | 0.030 |
Why?
|
| Pancreatic Function Tests | 1 | 1995 | 69 | 0.030 |
Why?
|
| Light | 1 | 2001 | 1344 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2000 | 1035 | 0.030 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 1995 | 86 | 0.030 |
Why?
|
| Lactates | 1 | 1995 | 404 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2015 | 452 | 0.030 |
Why?
|
| p-Aminohippuric Acid | 1 | 2014 | 36 | 0.030 |
Why?
|
| Adipocytes, White | 1 | 2015 | 91 | 0.030 |
Why?
|
| Gallbladder Emptying | 1 | 1994 | 14 | 0.030 |
Why?
|
| Rabbits | 3 | 2011 | 4773 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2014 | 201 | 0.030 |
Why?
|
| Chromaffin System | 1 | 1994 | 15 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 1999 | 621 | 0.030 |
Why?
|
| Nitroglycerin | 1 | 1995 | 329 | 0.030 |
Why?
|
| HLA-DR Antigens | 1 | 1996 | 630 | 0.030 |
Why?
|
| Heart Failure | 1 | 2018 | 11847 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 1999 | 992 | 0.030 |
Why?
|
| Glycoprotein Hormones, alpha Subunit | 1 | 1994 | 95 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2018 | 1792 | 0.030 |
Why?
|
| Pregnenolone | 1 | 1993 | 27 | 0.030 |
Why?
|
| Androstenedione | 1 | 1994 | 131 | 0.030 |
Why?
|
| Crystallization | 1 | 1995 | 533 | 0.030 |
Why?
|
| Transfection | 3 | 1998 | 5781 | 0.030 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 1993 | 27 | 0.030 |
Why?
|
| Steroid 11-beta-Hydroxylase | 1 | 1993 | 20 | 0.030 |
Why?
|
| Family Health | 1 | 1999 | 1257 | 0.030 |
Why?
|
| Benzimidazoles | 1 | 1999 | 858 | 0.030 |
Why?
|
| Neuroendocrine Tumors | 1 | 2000 | 650 | 0.030 |
Why?
|
| Rats, Inbred WKY | 1 | 1993 | 151 | 0.030 |
Why?
|
| Pyrroles | 1 | 2020 | 1137 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2007 | 8555 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 2014 | 2558 | 0.030 |
Why?
|
| Cell Line | 6 | 2001 | 15620 | 0.030 |
Why?
|
| Receptors, Leptin | 1 | 2015 | 350 | 0.030 |
Why?
|
| NAD | 1 | 2017 | 609 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1995 | 941 | 0.030 |
Why?
|
| Heart Injuries | 1 | 2015 | 208 | 0.030 |
Why?
|
| Tetrazoles | 1 | 1999 | 905 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2012 | 829 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 1999 | 2852 | 0.030 |
Why?
|
| Abdomen | 1 | 1999 | 1130 | 0.030 |
Why?
|
| Endotoxins | 1 | 1995 | 521 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2012 | 9716 | 0.030 |
Why?
|
| Imidazoles | 1 | 1999 | 1180 | 0.030 |
Why?
|
| Hypertriglyceridemia | 1 | 2016 | 316 | 0.030 |
Why?
|
| Linear Models | 2 | 2014 | 5877 | 0.030 |
Why?
|
| Postoperative Period | 1 | 1998 | 1818 | 0.030 |
Why?
|
| Hypoaldosteronism | 1 | 1992 | 7 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 1628 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2003 | 2093 | 0.030 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 1999 | 1031 | 0.030 |
Why?
|
| Reactive Oxygen Species | 2 | 2014 | 2138 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2003 | 2881 | 0.030 |
Why?
|
| Radioimmunoassay | 2 | 1990 | 866 | 0.030 |
Why?
|
| Anisomycin | 1 | 1992 | 27 | 0.030 |
Why?
|
| Antigens | 1 | 1998 | 1447 | 0.030 |
Why?
|
| Prevalence | 5 | 2016 | 15687 | 0.030 |
Why?
|
| Neoplasms | 2 | 2018 | 22072 | 0.030 |
Why?
|
| Point Mutation | 1 | 1997 | 1594 | 0.030 |
Why?
|
| Insulin-Secreting Cells | 1 | 2020 | 907 | 0.030 |
Why?
|
| Perception | 1 | 1999 | 1195 | 0.030 |
Why?
|
| Xenopus | 1 | 2014 | 717 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2003 | 3022 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2006 | 474 | 0.030 |
Why?
|
| Biological Transport | 1 | 1997 | 2086 | 0.030 |
Why?
|
| Cloning, Molecular | 4 | 1998 | 4169 | 0.030 |
Why?
|
| Sirolimus | 1 | 1999 | 1547 | 0.020 |
Why?
|
| Aged, 80 and over | 5 | 2010 | 58995 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2018 | 1112 | 0.020 |
Why?
|
| Obesity, Abdominal | 1 | 2015 | 374 | 0.020 |
Why?
|
| Vitamin D | 2 | 2018 | 3291 | 0.020 |
Why?
|
| Thymine | 1 | 2012 | 69 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1992 | 189 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 667 | 0.020 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 12159 | 0.020 |
Why?
|
| DNA Replication | 3 | 1984 | 1412 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2001 | 2860 | 0.020 |
Why?
|
| Genes | 2 | 1999 | 1845 | 0.020 |
Why?
|
| Subcutaneous Fat | 1 | 2015 | 393 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2004 | 4013 | 0.020 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2011 | 18 | 0.020 |
Why?
|
| Parathyroid Glands | 1 | 2013 | 517 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 877 | 0.020 |
Why?
|
| Aerosols | 1 | 2014 | 632 | 0.020 |
Why?
|
| Cell Cycle Proteins | 2 | 2001 | 3446 | 0.020 |
Why?
|
| Iron | 1 | 2000 | 1786 | 0.020 |
Why?
|
| Metabolome | 1 | 2018 | 982 | 0.020 |
Why?
|
| Cytosine | 1 | 2012 | 212 | 0.020 |
Why?
|
| Carrier Proteins | 2 | 2001 | 4938 | 0.020 |
Why?
|
| Guanine | 1 | 2012 | 278 | 0.020 |
Why?
|
| Mice, Transgenic | 3 | 2015 | 9530 | 0.020 |
Why?
|
| Pedigree | 1 | 1998 | 4578 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 600 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2013 | 1974 | 0.020 |
Why?
|
| Anthropometry | 1 | 1995 | 1348 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 9411 | 0.020 |
Why?
|
| S Phase | 2 | 2001 | 422 | 0.020 |
Why?
|
| Logistic Models | 3 | 2012 | 13314 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3584 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 1998 | 1998 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2014 | 1895 | 0.020 |
Why?
|
| Blood Proteins | 2 | 1999 | 1173 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2007 | 4744 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2001 | 319 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2010 | 26181 | 0.020 |
Why?
|
| Saponins | 1 | 1989 | 50 | 0.020 |
Why?
|
| Subcellular Fractions | 2 | 2001 | 532 | 0.020 |
Why?
|
| Freudian Theory | 1 | 1989 | 32 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2017 | 1607 | 0.020 |
Why?
|
| Recombination, Genetic | 2 | 1998 | 1526 | 0.020 |
Why?
|
| Osteoporosis | 1 | 1999 | 1600 | 0.020 |
Why?
|
| Cholestenone 5 alpha-Reductase | 1 | 2008 | 21 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 1132 | 0.020 |
Why?
|
| Eating | 1 | 1995 | 1539 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2000 | 1952 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 1995 | 1341 | 0.020 |
Why?
|
| Ileum | 2 | 2003 | 555 | 0.020 |
Why?
|
| Transcriptional Activation | 3 | 2001 | 1755 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1998 | 1796 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1996 | 4899 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 1997 | 1894 | 0.020 |
Why?
|
| Bacteriophage lambda | 1 | 1988 | 142 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2009 | 15697 | 0.020 |
Why?
|
| Digoxin | 1 | 1989 | 247 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2004 | 14495 | 0.020 |
Why?
|
| Feedback | 1 | 1992 | 791 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 2008 | 195 | 0.020 |
Why?
|
| Cell Division | 3 | 2000 | 4463 | 0.020 |
Why?
|
| Endothelial Cells | 2 | 2011 | 3539 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2394 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 489 | 0.020 |
Why?
|
| Chromogranin A | 2 | 2000 | 49 | 0.020 |
Why?
|
| Action Potentials | 1 | 2015 | 1816 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2010 | 629 | 0.020 |
Why?
|
| Saphenous Vein | 1 | 2011 | 537 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 1988 | 140 | 0.020 |
Why?
|
| Carcinoma | 1 | 1999 | 2331 | 0.020 |
Why?
|
| Receptors, CCR2 | 1 | 2009 | 215 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 1988 | 455 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 36060 | 0.020 |
Why?
|
| Isometric Contraction | 1 | 2008 | 146 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2001 | 608 | 0.020 |
Why?
|
| Immunohistochemistry | 4 | 2011 | 11071 | 0.020 |
Why?
|
| Genetics, Medical | 1 | 2010 | 336 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2008 | 257 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 1376 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 3800 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2009 | 981 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2012 | 1996 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 2 | 1999 | 321 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1999 | 8158 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2002 | 15840 | 0.020 |
Why?
|
| Chromosome Mapping | 4 | 1998 | 4625 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 5791 | 0.020 |
Why?
|
| Staphylococcus aureus | 3 | 1984 | 1462 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2011 | 951 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2448 | 0.020 |
Why?
|
| Receptors, CCR5 | 1 | 2009 | 488 | 0.020 |
Why?
|
| Piperidines | 1 | 2015 | 1650 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 1 | 2007 | 325 | 0.020 |
Why?
|
| Administration, Oral | 3 | 2000 | 4035 | 0.020 |
Why?
|
| Anger | 1 | 1989 | 401 | 0.020 |
Why?
|
| Adenine | 1 | 2012 | 975 | 0.020 |
Why?
|
| Bacterial Proteins | 4 | 1999 | 3826 | 0.020 |
Why?
|
| Vasopressins | 1 | 1987 | 355 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3465 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2016 | 4000 | 0.020 |
Why?
|
| Health | 1 | 2008 | 396 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 2180 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 1995 | 8552 | 0.020 |
Why?
|
| Europe | 1 | 2012 | 3441 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2015 | 5434 | 0.020 |
Why?
|
| Growth Hormone | 1 | 1987 | 568 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 8056 | 0.020 |
Why?
|
| Vitis | 1 | 2004 | 19 | 0.020 |
Why?
|
| Coronary Disease | 1 | 1999 | 5990 | 0.020 |
Why?
|
| Recurrence | 2 | 1995 | 8482 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2011 | 2608 | 0.020 |
Why?
|
| Analgesics | 1 | 1992 | 1065 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2007 | 933 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2018 | 4373 | 0.010 |
Why?
|
| Alanine | 2 | 1997 | 606 | 0.010 |
Why?
|
| Butylscopolammonium Bromide | 1 | 2003 | 2 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2008 | 1690 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1985 | 2094 | 0.010 |
Why?
|
| Mathematical Computing | 1 | 2003 | 143 | 0.010 |
Why?
|
| Ecdysone | 1 | 2003 | 19 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1995 | 4219 | 0.010 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 1994 | 99 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2003 | 361 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 2003 | 91 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 2 | 2001 | 3618 | 0.010 |
Why?
|
| Body Fluid Compartments | 1 | 2002 | 50 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2009 | 1513 | 0.010 |
Why?
|
| Psychophysiologic Disorders | 1 | 2004 | 221 | 0.010 |
Why?
|
| Adrenergic alpha-1 Receptor Agonists | 1 | 2002 | 18 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 2 | 1998 | 553 | 0.010 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2002 | 24 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2017 | 24123 | 0.010 |
Why?
|
| Brain | 1 | 2009 | 26951 | 0.010 |
Why?
|
| Half-Life | 1 | 2003 | 652 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2003 | 224 | 0.010 |
Why?
|
| Mathematics | 1 | 2003 | 707 | 0.010 |
Why?
|
| Biglycan | 1 | 2001 | 10 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2002 | 352 | 0.010 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2001 | 73 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 5961 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2002 | 174 | 0.010 |
Why?
|
| Cyclin A | 1 | 2001 | 60 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2010 | 1089 | 0.010 |
Why?
|
| Graves Disease | 1 | 1983 | 239 | 0.010 |
Why?
|
| Pain Measurement | 1 | 1992 | 3528 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2717 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 1997 | 2506 | 0.010 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2001 | 121 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1998 | 9185 | 0.010 |
Why?
|
| G2 Phase | 1 | 2001 | 133 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2001 | 295 | 0.010 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2001 | 123 | 0.010 |
Why?
|
| Central Nervous System Depressants | 1 | 2002 | 164 | 0.010 |
Why?
|
| DNA, Bacterial | 2 | 1984 | 1456 | 0.010 |
Why?
|
| Natriuresis | 1 | 2001 | 105 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 2003 | 465 | 0.010 |
Why?
|
| Child, Preschool | 4 | 2012 | 42063 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2001 | 2919 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2001 | 283 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2000 | 68 | 0.010 |
Why?
|
| Radiography | 2 | 2003 | 6965 | 0.010 |
Why?
|
| Erythrocyte Membrane | 1 | 1982 | 439 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1998 | 6315 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3442 | 0.010 |
Why?
|
| Transcription Factor RelB | 1 | 1999 | 28 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2008 | 1881 | 0.010 |
Why?
|
| Liver Neoplasms | 2 | 1994 | 4319 | 0.010 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1999 | 122 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1999 | 148 | 0.010 |
Why?
|
| Immunoglobulin G | 2 | 1999 | 4541 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 1999 | 60 | 0.010 |
Why?
|
| Barium Sulfate | 1 | 2000 | 180 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2000 | 8547 | 0.010 |
Why?
|
| Beverages | 1 | 2004 | 820 | 0.010 |
Why?
|
| Placenta | 1 | 1988 | 1702 | 0.010 |
Why?
|
| Cyclin E | 1 | 1999 | 155 | 0.010 |
Why?
|
| Intestinal Fistula | 1 | 2000 | 143 | 0.010 |
Why?
|
| Nucleic Acid Precursors | 1 | 1998 | 15 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 835 | 0.010 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2000 | 324 | 0.010 |
Why?
|
| Blood Group Antigens | 1 | 1960 | 187 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2000 | 331 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 2001 | 495 | 0.010 |
Why?
|
| Genome, Human | 1 | 2012 | 4417 | 0.010 |
Why?
|
| Sulfapyridine | 1 | 1998 | 5 | 0.010 |
Why?
|
| Thiocarbamates | 1 | 1998 | 30 | 0.010 |
Why?
|
| Cathepsin B | 1 | 1998 | 80 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 16939 | 0.010 |
Why?
|
| DNA Probes | 1 | 1999 | 551 | 0.010 |
Why?
|
| Tyrosine | 1 | 2002 | 1438 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 1999 | 394 | 0.010 |
Why?
|
| Nucleotide Mapping | 1 | 1997 | 19 | 0.010 |
Why?
|
| Phorbol Esters | 1 | 1998 | 108 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 854 | 0.010 |
Why?
|
| Wilms Tumor | 1 | 2001 | 375 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1998 | 251 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 1173 | 0.010 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2000 | 380 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2006 | 2326 | 0.010 |
Why?
|
| Chelating Agents | 1 | 1999 | 384 | 0.010 |
Why?
|
| Cystine | 1 | 1998 | 94 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 2001 | 670 | 0.010 |
Why?
|
| Vacuoles | 1 | 1998 | 229 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2001 | 698 | 0.010 |
Why?
|
| Magnesium Sulfate | 1 | 1998 | 73 | 0.010 |
Why?
|
| Birth Order | 1 | 1998 | 95 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 2001 | 755 | 0.010 |
Why?
|
| Mental Status Schedule | 1 | 1998 | 314 | 0.010 |
Why?
|
| Testosterone | 1 | 2008 | 2470 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2001 | 2014 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 642 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2001 | 1234 | 0.010 |
Why?
|
| Portal Pressure | 1 | 1997 | 60 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2001 | 656 | 0.010 |
Why?
|
| Turkey | 1 | 1998 | 249 | 0.010 |
Why?
|
| Mesalamine | 1 | 1998 | 136 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 426 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1997 | 777 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2001 | 556 | 0.010 |
Why?
|
| Nitrogen Isotopes | 1 | 1997 | 85 | 0.010 |
Why?
|
| Deuterium | 1 | 1997 | 105 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1999 | 777 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1998 | 347 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1997 | 273 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2002 | 2222 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1998 | 419 | 0.010 |
Why?
|
| Colonic Diseases | 1 | 1998 | 200 | 0.010 |
Why?
|
| Family Practice | 1 | 1999 | 510 | 0.010 |
Why?
|
| Proline | 1 | 1998 | 457 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1999 | 1705 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1999 | 979 | 0.010 |
Why?
|
| Apolipoprotein E4 | 1 | 2000 | 707 | 0.010 |
Why?
|
| Abscess | 1 | 2000 | 605 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2001 | 2057 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1996 | 195 | 0.010 |
Why?
|
| Mammals | 1 | 2001 | 1131 | 0.010 |
Why?
|
| Genes, Neoplasm | 1 | 1998 | 370 | 0.010 |
Why?
|
| Chymotrypsinogen | 1 | 1975 | 5 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 1246 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 2 | 1998 | 4713 | 0.010 |
Why?
|
| Virulence | 1 | 1999 | 1298 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2001 | 1326 | 0.010 |
Why?
|
| Ethanol | 1 | 2002 | 1323 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1996 | 241 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1996 | 224 | 0.010 |
Why?
|
| HLA-DQ Antigens | 1 | 1996 | 211 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 1999 | 670 | 0.010 |
Why?
|
| ras Proteins | 1 | 2001 | 1052 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2001 | 1139 | 0.010 |
Why?
|
| Introns | 1 | 1998 | 978 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2002 | 2192 | 0.010 |
Why?
|
| Gluconeogenesis | 1 | 1996 | 185 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2001 | 3105 | 0.010 |
Why?
|
| Amylases | 1 | 1975 | 169 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1999 | 1529 | 0.010 |
Why?
|
| Carbachol | 1 | 1975 | 223 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 1998 | 749 | 0.010 |
Why?
|
| Parity | 1 | 1998 | 925 | 0.010 |
Why?
|
| Glyburide | 1 | 1975 | 114 | 0.010 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 1996 | 318 | 0.010 |
Why?
|
| Comorbidity | 1 | 2009 | 10551 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1998 | 814 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2016 | 80372 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1999 | 1201 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 1999 | 1077 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 1999 | 1155 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 1997 | 568 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1982 | 2611 | 0.010 |
Why?
|
| Leucine | 1 | 1975 | 547 | 0.010 |
Why?
|
| Placebos | 1 | 1998 | 1668 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 1999 | 1468 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1998 | 1608 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1998 | 2176 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2001 | 1728 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1999 | 1132 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2000 | 1484 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 2696 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2001 | 2379 | 0.010 |
Why?
|
| Lipase | 1 | 1975 | 324 | 0.010 |
Why?
|
| Survival Rate | 2 | 1999 | 12808 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1998 | 1955 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3735 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1997 | 2753 | 0.010 |
Why?
|
| Lysosomes | 1 | 1998 | 920 | 0.010 |
Why?
|
| Dietary Proteins | 1 | 1998 | 949 | 0.010 |
Why?
|
| Binding Sites | 1 | 2001 | 6048 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1998 | 1187 | 0.010 |
Why?
|
| Hydroxyurea | 1 | 1994 | 282 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1998 | 1745 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2001 | 2414 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1998 | 2932 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 6216 | 0.010 |
Why?
|
| Internal Medicine | 1 | 1999 | 1048 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1996 | 951 | 0.010 |
Why?
|
| Piperazines | 1 | 2002 | 2525 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1999 | 2934 | 0.010 |
Why?
|
| RNA | 1 | 2001 | 2722 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 12626 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2000 | 2864 | 0.010 |
Why?
|
| Amino Acids | 1 | 1997 | 1714 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 1998 | 981 | 0.010 |
Why?
|
| Child | 4 | 2001 | 79806 | 0.010 |
Why?
|
| Educational Status | 1 | 1998 | 2515 | 0.010 |
Why?
|
| Antioxidants | 1 | 1998 | 1667 | 0.010 |
Why?
|
| Cardenolides | 1 | 1989 | 17 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1994 | 1089 | 0.010 |
Why?
|
| Biopsy | 1 | 2001 | 6771 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1994 | 1735 | 0.000 |
Why?
|
| Pancreatic Pseudocyst | 1 | 1989 | 110 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 6538 | 0.000 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1988 | 100 | 0.000 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 2282 | 0.000 |
Why?
|
| Genetic Testing | 1 | 2000 | 3531 | 0.000 |
Why?
|
| Population Surveillance | 1 | 1998 | 2608 | 0.000 |
Why?
|
| Methotrexate | 1 | 1994 | 1719 | 0.000 |
Why?
|
| Aspirin | 1 | 1998 | 3364 | 0.000 |
Why?
|
| Bone Density | 1 | 1999 | 3534 | 0.000 |
Why?
|
| Neuropsychological Tests | 1 | 1998 | 7021 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 20080 | 0.000 |
Why?
|
| Tetracycline | 1 | 1984 | 220 | 0.000 |
Why?
|
| Swine | 1 | 1994 | 5899 | 0.000 |
Why?
|
| Disease Progression | 1 | 2001 | 13502 | 0.000 |
Why?
|
| Replicon | 1 | 1982 | 34 | 0.000 |
Why?
|
| Methods | 1 | 1983 | 1074 | 0.000 |
Why?
|
| Antibody Affinity | 1 | 1983 | 245 | 0.000 |
Why?
|
| Fibrosis | 1 | 1989 | 2042 | 0.000 |
Why?
|
| Drug Resistance, Microbial | 1 | 1984 | 856 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1994 | 2299 | 0.000 |
Why?
|
| Hospital Mortality | 1 | 1995 | 5425 | 0.000 |
Why?
|
| Chromosome Deletion | 1 | 1984 | 1387 | 0.000 |
Why?
|
| Gestational Age | 1 | 1988 | 3565 | 0.000 |
Why?
|